Loading...
Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
BACKGROUND: Survival benefit of neoadjuvant chemotherapy (NAC) for advanced gastric cancer (AGC) is a debatable issue. Studies have shown that the survival benefit of NAC is dependent on the pathological response to chemotherapy drugs. For those who achieve pathological complete response (pCR), NAC...
Na minha lista:
| Udgivet i: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243641/ https://ncbi.nlm.nih.gov/pubmed/32476803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i19.2427 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|